These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 33694292)
1. The immune landscape during the tumorigenesis of cervical cancer. Wang Y; He M; Zhang G; Cao K; Yang M; Zhang H; Liu H Cancer Med; 2021 Apr; 10(7):2380-2395. PubMed ID: 33694292 [TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8 Rotman J; Heeren AM; Gassama AA; Lougheed SM; Pocorni N; Stam AGM; Bleeker MCG; Zijlmans HJMAA; Mom CH; Kenter GG; Jordanova ES; de Gruijl TD Clin Cancer Res; 2020 Jul; 26(14):3791-3802. PubMed ID: 32220890 [TBL] [Abstract][Full Text] [Related]
3. Dissecting the Single-Cell Transcriptome Network of Immune Environment Underlying Cervical Premalignant Lesion, Cervical Cancer and Metastatic Lymph Nodes. Li C; Hua K Front Immunol; 2022; 13():897366. PubMed ID: 35812401 [TBL] [Abstract][Full Text] [Related]
5. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer. Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314 [TBL] [Abstract][Full Text] [Related]
6. The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy. Abdulrahman Z; Kortekaas KE; De Vos Van Steenwijk PJ; Van Der Burg SH; Van Poelgeest MI Expert Opin Biol Ther; 2018 Dec; 18(12):1223-1233. PubMed ID: 30373410 [TBL] [Abstract][Full Text] [Related]
7. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas. Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402 [TBL] [Abstract][Full Text] [Related]
8. Identification of cervical cancer stem cells using single-cell transcriptomes of normal cervix, cervical premalignant lesions, and cervical cancer. Zhang T; Zhuang L; Muaibati M; Wang D; Abasi A; Tong Q; Ma D; Jin L; Huang X EBioMedicine; 2023 Jun; 92():104612. PubMed ID: 37224771 [TBL] [Abstract][Full Text] [Related]
9. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900 [TBL] [Abstract][Full Text] [Related]
10. [Value of 4-quadrant biopsies under colposcopy for detecting precancerous lesions in cervical cancer screening]. Zhao Y; Song Y; Zhao F; Zhang W; Li L; Chen F; Chen W; Pan Q; Shen G; Qiao Y Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):875-9. PubMed ID: 26887523 [TBL] [Abstract][Full Text] [Related]
11. Sequencing-based transcriptome analysis reveals diversification of immune response- and angiogenesis-related expression patterns of early-stage cervical carcinoma as compared with high-grade CIN. Kurmyshkina OV; Dobrynin PV; Kovchur PI; Volkova TO Front Immunol; 2023; 14():1215607. PubMed ID: 37731500 [TBL] [Abstract][Full Text] [Related]
12. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance. Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840 [TBL] [Abstract][Full Text] [Related]
13. Comparative transcriptomic profiling in HPV-associated cervical carcinogenesis: Implication of MHC class II and immunoglobulin heavy chain genes. Balasubramaniam SD; Wong KK; Oon CE; Balakrishnan V; Kaur G Life Sci; 2020 Sep; 256():118026. PubMed ID: 32615187 [TBL] [Abstract][Full Text] [Related]
14. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283 [TBL] [Abstract][Full Text] [Related]
16. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area. Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490 [TBL] [Abstract][Full Text] [Related]
17. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients. Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013 [TBL] [Abstract][Full Text] [Related]
18. Systematic identification of key genes and pathways in the development of invasive cervical cancer. Niu G; Wang D; Pei Y; Sun L Gene; 2017 Jun; 618():28-41. PubMed ID: 28341182 [TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix. Missaoui N; Hmissa S; Trabelsi A; Traoré C; Mokni M; Dante R; Frappart L Pathol Res Pract; 2011 Jan; 207(1):37-42. PubMed ID: 21129853 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory Stroma of Lymphoepithelioma-like Carcinoma of the Cervix: Immunohistochemical Study of 3 Cases and Review of the Literature. Philippe A; Rassy M; Craciun L; Naveaux C; Willard-Gallo K; Larsimont D; Veys I Int J Gynecol Pathol; 2018 Sep; 37(5):482-487. PubMed ID: 28985196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]